DUBLIN, June 24, 2021--(BUSINESS WIRE)--The "Global Antacids Market (2021-2026), by Drug Class, Formulation, Distribution Channel, Geography and the Impact of COVID-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
Antacids are usually over the counter (OTC) medications used in neutralizing stomach acid. The market has seen wide availability of antacids in variety of forms. Manufacturers in the antacids market are approaching different drug formulation techniques to support flavoured, chewable tablets to capture the market.
The Global Antacids Market is estimated to be USD 5.5 Bn in 2021 and is expected to reach USD 6.56 Bn by 2026 growing at a CAGR of 3.6%.
Rising incidence of acidic refluxes like GERD, unhealthy lifestyle etc. have driven the growth of the market. However, the alternative market for antacids hinders the growth of this market.
The Global Antacid market is further segmented on the basis of drug class, formulation, distribution channel and geography.
Global Antacids Market, By Drug Class
Proton Pump Inhibitor
Global Antacids Market, By Formulation
Global Antacids Market, By Distribution Channel
Global Antacids Market, By Geography
Middle East and Africa
Why buy this report?
The report offers a comprehensive evaluation of the Global Antacids Market.
The report includes in-depth qualitative analysis, verifiable data from authentic sources and projections about market size. The projections are calculated using proven research methodologies.
The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys and observation of renowned personnel in the industry.
The report includes in-depth market analysis using Porter's 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.
The report also contains the competitive analysis using Competitive Quadrant, the analyst's proprietary competitive positioning tool.
A complete analysis of the market including parent industry
Important market dynamics and trends
Historical, current, and projected size of the market based on value and volume
Market shares and strategies of key players
Recommendations to companies for strengthening their foothold in the market
Increasing Prevalence of Gastro Esophageal Reflux Diseases (GERD)
Growing Geriatric Population
Increasing Prevalence Of Heartburn
Growing number of alternatives in the market for antacids
Increasing awareness about GERD
Rise of E-commerce has augmented the demand for antacids
Melt in mouth antacid
Johnson & Johnson
Novartis Consumer Health
Boehringer Ingelheim Pharm
Procter & Gamble
First Aid Only
Dr Reddy's Laboratories
Reckitt Benckiser Group plc
Takeda Pharmaceutical Company Limited
For more information about this report visit https://www.researchandmarkets.com/r/vnvzsy
View source version on businesswire.com: https://www.businesswire.com/news/home/20210624005668/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900